Variables

Active surveillance

Surgery

Radiation

Median age, years (IQR)

65 (59-70)

61 (56-66)

66 (61-70)

Age, % (n)

45-55

55.1-65

65.1-75

>75

13% (4248)

41% (13739)

38% (12689)

8% (2531)

23% (19331)

51% (42031)

25% (20831)

1% (960)

9% (4549)

38% (19376)

44% (22367)

9% (4216)

Race, % (n)

White

Black

Other

81% (26984)

14% (4513)

4% (1710)

84% (70009)

12% (9978)

4% (3166)

79% (39979)

17% (8839)

4% (1690)

Charlson score, % (n)

0

1

2

>3

87% (28829)

10% (3410)

2% (661)

1% (307)

83% (68769)

14% (12148)

2% (1714)

1% (522)

84% (42334)

13% (6546)

2% (1164)

1% (464)

Treatment center, % (n)

Academic

Cancer center (non-academic)

Community practice

54% (17964)

10% (3258)

36% (11985)

44% (36814)

14% (11328)

42% (35011)

33% (16550)

14% (7293)

53% (26665)

Insurance, % (n)

Medicare

Medicaid

Private

Self

44% (14141)

3% (1020)

51% (16413)

2% (702)

30% (24097)

2% (1645)

67% (54348)

1% (910)

52% (25042)

3% (1424)

44% (20998)

1% (593)

Median Distance to treatment facility, miles (IQR)

11 (5-26)

14 (6-36)

10 (5-22)

NCCN risk, % (n)*

LR-PC

FIR-GG1

FIR-GG2

81% (27064)

9% (2716)

10% (3427)

58% (49850)

7% (3922)

35% (29381)

56% (28686)

8% (3397)

36% (18425)

Median PSA, ng/ml (IQR)

5.6 (4.4-7.3)

5.2 (4.2-6.7)

5.6 (4.5-7.3)

Percent of positive cores, % (n)

16 (8-25)

25 (15-36)

25 (16-33)